54864-89-0 Usage
General Description
6-(4-methylpiperazin-1-yl)nicotinonitrile is a chemical compound with the molecular formula C12H15N5. It is a derivative of nicotinonitrile with a methylpiperazine group attached to the 6-position. 6-(4-METHYLPIPERAZIN-1-YL)NICOTINONITRILE has potential pharmaceutical applications, particularly in the development of drugs for the treatment of various diseases and conditions. It may have biological activity as a ligand for certain receptors or enzymes, and further research and testing are needed to determine its specific pharmacological properties. Additionally, it may also have uses in chemical synthesis or as a building block for the development of other organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 54864-89-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,8,6 and 4 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 54864-89:
(7*5)+(6*4)+(5*8)+(4*6)+(3*4)+(2*8)+(1*9)=160
160 % 10 = 0
So 54864-89-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N4/c1-14-4-6-15(7-5-14)11-3-2-10(8-12)9-13-11/h2-3,9H,4-7H2,1H3
54864-89-0Relevant articles and documents
Benzoquinone derivative, pharmaceutical composition, and applications thereof
-
Paragraph 0213-0216, (2019/11/29)
The invention discloses a benzoquinone derivative, a pharmaceutical composition, and applications thereof. According to the invention, the benzoquinone derivative (I), and the stereoisomer or the pharmaceutically acceptable salt thereof possess a structure disclosed in the invention. The benzoquinone derivative possesses excellent inhibition effect on STAT3 level both in vivo and in vitro, and further, the benzoquinone derivative is capable of inhibiting balling capacity of cancer cells.
C-Piperazino-pyridine sulfonamides
-
, (2008/06/13)
This invention relates to compounds of the formula: SPC1 Wherein R1 in the 3- or 5-position is preferably a substituted sulfonamido or a carboxamido group whereas R2 in the 2-, 4- or 6-position is preferably an alkyl- or hydroxyalkyl-piperazinyl group. Said compounds may be used as anti-inflammatory and cardiovascular agents.
